Summary
This prediction ended on 05.12.18 with a price of €65.75. With a performance of -9.51%, the BUY prediction for Bayer AG by DirectorDealer closed slightly in the red. DirectorDealer has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. DirectorDealer has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 4.805% | 4.805% | 94.205% | -0.296% |
| iShares Core DAX® | 1.770% | 3.450% | 5.562% | 60.302% |
| iShares Nasdaq 100 | -3.500% | 1.607% | 32.311% | 88.100% |
| iShares Nikkei 225® | -4.942% | 4.221% | 57.828% | 75.066% |
| iShares S&P 500 | 0.300% | 2.580% | 24.810% | 69.261% |
Comments by DirectorDealer for this prediction
In the thread Bayer AG diskutieren
Director's Dealing: Buy
Director's Dealing / Insider Kauf von Klusik, Dr. Hartmut (Geschäftsführendes Organ)
- Handelstag: 07.09.18
- Volumen: 145127 €
- Meldender: Klusik, Dr. Hartmut
sharewise.com analyzes all insider trades. The biggest trades generate automatic predictions. Additional information can be found in DirectorDealer's profile.
(Durch neue Einschätzung ersetzt)